MediWound(MDWD)
搜索文档
MediWound(MDWD) - 2022 Q4 - Earnings Call Transcript
2023-03-17 02:30
MediWound Ltd. (NASDAQ:MDWD) Q4 2022 Earnings Conference Call March 16, 2023 8:30 AM ET Company Participants Monique Kosse - LifeSci Advisors, IR Ofer Gonen - Chief Executive Officer Boaz Gur-Lavie - Chief Financial Officer Conference Call Participants Josh Jennings - TD Cowen Francois Brisebois - Oppenheimer Swayampakula Ramakanth - H.C. Wainwright Michael Okunewitch - Maxim Group Operator Good day. And welcome to MediWound???s Fourth Quarter and Year End 2022 Earnings Call. Today???s conference is being r ...
Mediwound (MDWD) Investor Presentation - Slideshow
2023-03-17 02:14
| --- | --- | --- | |------------------------------------------------------------------------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Non-Surgical Biotherapeutic Solutions for Tissue Repair & Regeneration | | | | | | | | March 2023 I Nasdaq: MDWD | | | | --- ...
MediWound(MDWD) - 2023 Q1 - Quarterly Report
2023-03-16 19:15
Exhibit 99.1 MediWound Reports Fourth Quarter and Full Year 2022 Financial Results and Company Update 2022 total revenues of $26.5 million FDA approval of NexoBrid® in December 2022; U.S. commercial availability expected in the second quarter of 2023 EscharEx® Phase III protocol design is under review by the FDA; study to be initiated in the second half of 2023 Cash position of $66 million, including cash received for the NexoBrid approval milestone and recent equity financing Conference call begins today a ...
MediWound(MDWD) - 2022 Q4 - Annual Report
2023-03-16 19:05
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________________ to ____________________ OR ☐ SHELL COMPANY REPORT P ...
MediWound(MDWD) - 2022 Q3 - Earnings Call Transcript
2022-11-16 01:30
MediWound Ltd. (NASDAQ:MDWD) Q3 2022 Earnings Conference Call November 15, 2022 8:30 AM ET Company Participants Monique Kosse - MD, LifeSci Advisors Ofer Gonen - CEO Boaz Gur-Lavie - CFO Conference Call Participants Josh Jennings - Cowen Francois Brisebois - Oppenheimer Swayampakula Ramakanth - H.C. Wainwright Operator Good day, and welcome to the MediWound's Third Quarter 2022 Earnings Call. Today's conference call is being recorded. And at this time, I would like to turn the conference over to Monique Kos ...
MediWound(MDWD) - 2022 Q2 - Earnings Call Presentation
2022-08-10 12:36
| --- | --- | --- | |-------|-------|-------| | | | | | | | | | --- ...
MediWound(MDWD) - 2022 Q2 - Earnings Call Transcript
2022-08-10 12:31
MediWound Ltd. (NASDAQ:MDWD) Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Monique Kosse - Investor Relations Ofer Gonen - Chief Executive Officer Boaz Gur-Lavie - Chief Financial Officer Conference Call Participants Bryan Bergin - Cowen Ryan Zimmerman - BTIG Arthur He - H.C. Wainwright Operator Good day and welcome to MediWound???s Second Quarter 2022 Earnings Call. Today???s conference is being recorded. At this time, I would like to turn the conference over to Monique Ko ...
MediWound(MDWD) - 2022 Q1 - Earnings Call Transcript
2022-05-18 00:04
MediWound Ltd. (NASDAQ:MDWD) Q1 2022 Earnings Conference Call May 17, 2022 8:30 AM ET Company Participants Monique Kosse - IR Sharon Malka - CEO Boaz Gur-Lavie - Chief Financial Officer Ofer Gonen - Board Member Lior Rosenberg - Chief Medical Officer Cyaandi R. Dove - Investigator, Advanced Wound & Ankle Center, Las Vegas Conference Call Participants Unidentified Analyst - Cowen and Company Kevin DeGeeter - Oppenheimer Arthur He - H.C. Wainwright Operator Good day and welcome to the MediWound First Quarter ...
MediWound(MDWD) - 2021 Q4 - Earnings Call Transcript
2022-03-18 00:31
MediWound Ltd. (NASDAQ:MDWD) Q4 2021 Earnings Conference Call March 17, 2022 8:30 AM ET Company Participants Monique Kosse - Investor Relations Sharon Malka - Chief Executive Officer Boaz Gur-Lavie - Chief Financial Officer Conference Call Participants Josh Jennings - Cowen Kevin DeGeeter - Oppenheimer Ryan Zimmerman - BTIG Swayampakula Ramakanth - H.C. Wainwright Nathan Weinstein - Aegis Capital Operator Good day and thank you for standing by. Welcome to MediWound Fourth Quarter and Year End 2021 Conferenc ...
MediWound(MDWD) - 2021 Q3 - Earnings Call Transcript
2021-11-17 00:50
MediWound Ltd. (NASDAQ:MDWD) Q3 2021 Results Conference Call November 16, 2021 8:30 AM ET Company Participants Monique Kosse - LifeSci Advisors Sharon Malka - CEO Boaz Gur-Lavie - CFO Conference Call Participants Bryan Bergin - Cowen and Company Ryan Zimmerman - BTIG Kevin DeGeeter - Oppenheimer Swayampakula Ramakanth - H.C. Wainwright Operator Good day, and welcome to the MediWound Third Quarter 2021 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the call ...